Antonio Ciaccia

President of 3 Axis Advisors, where he provides drug pricing analytics and consulting support to plan sponsors, provider groups, state attorneys general, auditors, law firms, and government agencies. He is also the co-founder and CEO of 46brooklyn Research, a non-profit organization dedicated to improving the transparency and accessibility of drug pricing data for the American public.

"Medicines are life-changing and incredibly powerful. And with great power comes great responsibility. I support the work of RxGuardian because of the critical need for innovative solutions to protect against both intentional and unintentional misuse of dangerous drugs."